Table 1 Demographic and baseline characteristics of all patients
Parameters | Total (N = 349) | UME (n = 181) | Non-UME (n = 168) | P value |
|---|---|---|---|---|
Follow-up time (months), mean ± SD | 39.95 ± 33.65 | 36.65 ± 30.60 | 43.49 ± 36.41 | 0.058 |
Age (years), mean ± SD | 40.6 ± 16.6 | 42.2 ± 16.3 | 38.9 ± 16.7 | 0.063 |
Female gender, n (%) | 200 (57.3) | 97 (53.6) | 103 (61.3) | 0.150 |
Bilateral uveitis, n (%) | 190 (54.4) | 92 (50.8) | 98 (58.3) | 0.160 |
Chronic uveitis, n (%) | 255 (73.1) | 126 (69.6) | 129 (76.8) | 0.130 |
Location of inflammation, n (%) | ||||
Intermediate uveitis | 59 (16.9) | 20 (11.1) | 39 (23.2) | 0.009* |
Posterior uveitis | 144 (41.3) | 82 (45.3) | 62 (36.9) | |
Panuveitis | 146 (41.8) | 79 (43.7) | 67 (39.9) | |
Type of inflammation, n (%) | ||||
Granulomatous inflammation | 175 (50.1) | 90 (49.7) | 85 (50.6) | 0.870 |
Nongranulomatous inflammation | 174 (49.9) | 91 (50.3) | 83 (49.4) | |
Etiology, n (%) | ||||
Infection | 131 (37.5) | 85 (47.0) | 46 (27.4) | 0.001* |
Immune-mediated | 88 (25.2) | 37 (20.4) | 51 (30.4) | |
Idiopathic | 130 (37.3) | 59 (32.6) | 71 (42.3) | |
Diagnosis, n (%) | ||||
Tuberculosis | 44 (12.6) | 25 (13.8) | 19 (11.3) | |
ARN/PORN/CMVR | 42 (12) | 28 (15.5) | 14 (8.3) | |
Vogt-Koyanagi-Harada disease | 27 (7.7) | 16 (8.8) | 11 (6.5) | |
White dot syndrome | 19 (5.4) | 2 (1.1) | 17 (10.1) | |
Parasite-related uveitis | 18 (5.2) | 11 (6.1) | 7 (4.2) | |
Sarcoidosis | 17 (4.9) | 8 (4.4) | 9 (5.4) | |
Behçet’s disease | 13(3.7) | 6 (3.3) | 7 (4.2) | |
Syphilis | 9 (2.6) | 7 (3.9) | 2 (1.2) | |
HLA-B27/SNSA a | 7 (2) | 1 (0.5) | 6 (3.6) | |
Toxoplasmosis | 7 (2) | 6 (3.3) | 1 (0.6) | |
Cat-scratch neuroretinitis | 6 (1.7) | 4 (2.2) | 2 (1.2) | |
Endogenous endophthalmitis | 5 (1.4) | 4 (2.2) | 1 (0.6) | |
Juvenile idiopathic arthritis b | 3 (0.9) | 3 (1.7) | 0 | |
Systemic lupus erythematosus | 2 (0.6) | 1 (0.5) | 1 (0.6) | |
Maximal macular thickness (µm), mean ± SD | 358.11 ± 136.26 | 443.66 ± 142.29 | 265.94 ± 19.68 | < 0.001* |